结果自配溶血剂的各项性能指标都已达到原配溶血剂的水平,临床应用效果良好。
Results Our self-made hemolysis reagent's functions are compatible to import hemolysis, and have a good effect in clinic application.
东菱精纯克栓酶是一种单成分溶血栓促微循环的新型血栓治疗剂。
Batroxobin is a new thrombolytic drug, which is made up of single composition and can improve the blood microcirculation.
目的:了解葛根素注射剂致溶血反应的发生规律、相关因素和预后情况。
OBJECTIVE: to probe into the regular pattern, related factors and prognosis of hemolytic reactions induced by Puerarin injection.
应用推荐